Page results
-
Breathlessness (dyspnoea) is an unpleasant sensation of uncomfortable, rapid or difficult breathing.
-
UCLH Private Healthcare: world-class consultants, advanced treatments, and personalised care in central London.
-
Meet Mohammod, a booking coordinator in our Proton Beam Therapy unit, who supports patients and their families throughout their treatment.
-
We are expanding the type of results that will be shared with patients through our patient portal MyCare UCLH.
-
This page provides information about the use of venous sinus stents in the treatment of venous sinus stenosis and idiopathic intracranial hypertension (IIH).
-
This page provides information about endovascular treatment of Subdural Hematomas (SDH).
-
This page provides information about the sclerotherapy for low flow vascular malformations.
-
Information supporting adults affected by cancer and blood conditions being treated at UCLH.
-
Information for patients having chemotherapy for ovarian, tubal or primary peritoneal cancer, or who have been newly diagnosed with pancreatic cancer or cholangiocarcinoma.
-
This page has been written by the Neuropsychiatry Department at the National Hospital for Neurology and Neurosurgery. The aim of this page is to provide general information about the procedure called Repetitive Transcranial Magnetic Stimulation (rTMS).
File results
-
FOI/2023/0122 - Usage of Pembrolizumab for the treatment of melanoma
-
FOI/2023/0124 - Clinical decision support in e-prescribing, Observations vital signs, Oncology e-prescribing and Diagnostic imaging systems
-
FOI/2023/0126 - Repayment fees for internationally recruited nurses
-
FOI/2023/0127 - Organisational structure for finance managers
-
FOI/2023/0131 - Training for first aid, life support, CPR and resuscitation/ defibrillator
-
FOI/2023/0132 - Renal cell carcinoma and melanoma treatment
-
FOI/2023/0138 - Subject Access Requests (SARs) and Freedom of Information Requests
-
FOI/2023/0139 - Meningitis and Encephalitis guidelines/ pathway
-
FOI/2023/0142 - Treatment of breast cancer
-
FOI/2023/0143 - Immunoassay Analysers at Trust